Anyway, I just wanted to share with some others who might be considering an entry investment that I waded in and I will continue to purchase shares if/as there are continued rounds. With the optionality of combo trials, the risk reward is compelling. - lattices
Thank you for sharing lattices... and for one, I'm glad you've put some on the table. Personally, I think failure has pretty much been baked into share the price plus some. Yes, it could continue to spiral downwards if the company is forced to do yet another dilutive type of financing without significant news (although last Tuesday's news was really good, IMO). But the price is here because whose with enough shares to sell back and forth expect failure. And they are, at the very least, just here to help it along.
But... patients are all living longer, according to Linda Liau. And according to her, the comparison really boils down to this:
So in reality, I think, you know, what we’re really comparing now is actually early DC Vaccination versus later DC Vaccination (big smile). - Linda Liau
And if there's a big enough difference between these two subgroups, well... what to do, what to do? Each of the four countries (US, UK, Germany and Canada) will approach the data, when presented, in their own special way. Like Linda P says, there are four ways to win here.
Anyway, I wouldn't worry yourself over what some on this board might think... if you feel like communicating or have something to share, I hope you will do so.